Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for diabetic foot ulcer healing
ChiCTR2000029230Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sitagliptin in diabetic foot ulcer (DFU) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Ulcer area and Peripheral blood CD34+ stem cell count. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
sitagliptin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ChiCTR2000029230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029230.